A recurring critique in public discussion: documentation is often batch-level, while buyers reason about it as if it were vial-level.
Where this comes from
Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence. Observed in public discussion. PEPTD summarises the recurring theme — it does not republish anyone's post, profile or identity.
Community experience is anecdotal and is not medical advice. PEPTD does not convert discussion into recommended doses or protocols. Published research and regulatory sources are shown separately from public discussion.
Certificates of analysis are widely requested but far less widely understood. Public discussion repeatedly conflates identity, purity and sterility, which are different questions.
From public discussions · Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence.
Captured from r/Peptidesource
Threads about chromatography results often assume a single number settles quality, while others point out the limits of what any one assay establishes.
From public discussions · Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence.
Independent testing is frequently recommended, but the criteria for choosing a lab are rarely spelled out and vary between communities.
From public discussions · Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence.
From public discussions · Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence.
